SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
biotech binary events
An SI Board Since March 2003
Posts SubjectMarks Bans
295 36 0
Emcee:  dalroi Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
195FDA Advisory panel will review Exubera (NKTR, filing by PFE) on 9/8. Most Sep. phmpa-7/21/2005
194We are initiating coverage of Celgene Corp. (CELG; $40.57 N) with a Neutral RatiIcebrg-7/1/2005
193There shouldn't be any valuation attached to MT100 in Pozen, so imo, no realrkrw-6/29/2005
192Potential binary event. I don't know enough about Pozen to accurately assesIan@SI-6/29/2005
191July 25th PDUFA date for Adolor (ADLR): prous.com Don't follow the companytuck-6/23/2005
190July 15th will be a big day for Nymox (NYMX) and its test for AD: fda.gov It htuck-6/21/2005
189Neurochem Unblinds the Phase II/III Clinical Study for Fibrillex(TM) in the Treanigel bates-4/8/2005
188Maybe binary event from Barron's: online.barrons.com ARE THINGS LOOKING UPIan@SI-3/26/2005
187I could stand to be wrong under the circumstances! OK, someone give me some lkeokalani'nui-3/24/2005
186>> But timing is everything and P2 results precede even earliest anectdotescaram(o)uche-3/24/2005
185<i>You'll agree on this?? Any anecdote regarding a PR with either 6827keokalani'nui-3/24/2005
184100 person cancer sales force, marketing a highly profitable PM line. Three molscaram(o)uche-3/24/2005
183<i>financial risk if P2 bombs..</i> Short term, sure. I'd be bunigel bates-3/24/2005
182I agree mostly overall, but not as strongly, so I have a few shares. If P2 ADkeokalani'nui-3/24/2005
181I've been hesitant to post this, but the potential profit:loss is just way tscaram(o)uche-3/24/2005
180Encysive Pharmaceuticals Announces Topline Data From Stride-2 Pivotal Trial in Pnigel bates-2/14/2005
179(not sure this belongs on this thread) Last fall gnvc phase II TNFerade study haExtra Pale-1/31/2005
178Given where you got on the bus, I'd suggest you'd take a little money ofkeokalani'nui-1/31/2005
177end of April, beginning of May (my guess)..... MYGN and phase II results, R-fscaram(o)uche-1/31/2005
176This link is to a recent Signals article that puts in tabular form the drugs curtuck-1/5/2005
175Feuerstein's last list. [He will be leaving his job as a journalist at TheIcebrg-1/5/2005
174Axonyx Announces Completion of All Treatment Periods of Phase III Trial with Phenigel bates-12/28/2004
173Yes. There's always the chance of an appeal, but I don't think it will nigel bates-12/17/2004
172Would the upcoming (Monday) high court decision on the CATG/ABT royalty tussle btuck-12/17/2004
171PARS, shortly - Message 20843223nigel bates-12/9/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News